Luca Bertolaccini, MD, PhD

Surgery — European Institute of Oncology, Italy

LeadR Profile

Luca Bertolaccini, MD, PhD European Institute of Oncology Italy
1 652 ScienceLeadR Reputation 1652
Network Map

Surgery

Subspecialties: Oncology - Thoracic And Cardiovascular Surgery - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

European Institute of Oncology

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 515

Citations

Citations: 4 936 1st author: 202 Last author: 39 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Single-port robotic system approach for pulmonary lobectomy: our technique and preliminary results.
lung, safety, lymph node excision, neoplasms, lung neoplasms, carcinoid tumor
Updates Surg20260
Reply to: Regarding: Nachira D, Calabrese G, Bertolaccini L, et al. Oncological outcomes and prognostic factors of pulmonary metastasectomy in pancreatic cancer.
pancreatic neoplasms, neoplasms, metastasectomy, general surgery, prognosis
Updates Surg20260
Robotic Thoracic Surgery After Neoadjuvant Chemo-Immunotherapy for NSCLC: A Narrative Review.
thoracic surgery, lung, carcinoma, non-small-cell lung, immunotherapy, therapeutics, dissection
Cancers (Basel)20261
Epiproteomic profiling identifies histone H4 hyperacetylation as a prognostic marker in pleural mesothelioma.
cells, mesothelioma, neoplasms, lung neoplasms, histones, therapeutics, prognosis
Lung Cancer20260
From cytology to systems pathology: Decoding the molecular heterogeneity of resectable non-small-cell lung cancer.
cells, lung, neoplasms, pathology, carcinoma, non-small-cell lung, cell biology, lung neoplasms, small cell lung carcinoma, cytology
Cytojournal20260

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5

By status:

Unknown 2
Enrolling by invitation 1
Not yet recruiting 1
Recruiting 1

By type:

Observational 3
Interventional 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
NCT07325864 — cells, lung, neoplasms, carcinoma, non-small-cell lung, lung neoplasms, neoplasm metastasis, diagnosis, carcinoma
N/ARecruiting2025
Italian Lung Cancer Observational Study
NCT05851755 — lung, oncologists, neoplasms, lung neoplasms, male
N/AEnrolling by invitation2023
Prospective rAndomized sTudy efficaCy tHree dimensional rEconstructions Segmentectomy
NCT05716815 — lung, neoplasms, mastectomy, segmental, bronchi, lung neoplasms, thoracic surgery, video-assisted, anatomy
N/ANot yet recruiting2023

LeadR Networks

Main global connection map